How Can Generative AI Support Delivery in Your Clinical Trials?

Register Free: https://www.appliedclinicaltrialsonline.com/act/ai-support

Event overview

With Generative AI going mainstream, we will explore the benefits of Gen AI, how this will impact your clinical trial execution, and the potential risks to be mindful of. The world of clinical trials is heavily driven by generation of data and various documents which lends itself to the use of Generative AI for assisting clinical trials processes.
Key questions that come to mind as we consider the use of Generative AI in clinical trials are-

First, all of this must be weighed against the potential inherent risks that come with Generative AI such as AI hallucinations, data privacy, IP protection and the perceived risks of displacing the human role in the process. What will the future bring, and what is the right way forward? Join us for this important discussion.

Three key take-aways

Rajneesh Patil
Vice President, Clinical OperationsIQVIA

Rajneesh serves Clinical Operations at IQVIA as Head of Digital Strategy and Analytics Innovation. He is a gold medalist in Dental Surgery from India with Foundations in Public health from Australia and Digital Strategy- Executive from Harvard Business School, USA

Virupaxkumar Bonageri
Associate Director, Clinical Operations
IQVIA

Virupaxkumar is a technologist, Innovator, and Digital Transformation Leader with 15+ years of experience in driving business growth and efficiency using AI, analytics and automation to clinical operations to deliver differentiated outcomes in patient safety, site engagement, compliance and monitoring. He has a Masters in Software Engineering from the Birla Institute of Technology and Science, Pilani.